At the time of writing, Quest Diagnostics, Inc [DGX] stock is trading at $179.04, up 1.16%. An important factor to consider is whether the stock is rising or falling in short-term value. The DGX shares have gain 3.10% over the last week, with a monthly amount glided 2.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on April 02, 2025, when Redburn Atlantic initiated its Buy rating and assigned the stock a price target of $195. Previously, Citigroup downgraded its rating to Neutral on March 04, 2025, and kept the price target unchanged to $185. On January 06, 2025, upgrade upgraded it’s rating to Outperform and revised its price target to $174 on the stock. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $172 on December 17, 2024. Robert W. Baird upgraded its rating to Outperform for this stock on October 23, 2024, and upped its price target to $182.
For the past year, the stock price of Quest Diagnostics, Inc fluctuated between $135.47 and $179.99. Currently, Wall Street analysts expect the stock to reach $186.5 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $179.04 at the most recent close of the market. An investor can expect a potential return of 4.17% based on the average DGX price forecast.
Analyzing the DGX fundamentals
According to Quest Diagnostics, Inc [NYSE:DGX], the company’s sales were 10.16B for trailing twelve months, which represents an 12.09% jump. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Quest Diagnostics, Inc [NYSE:DGX] has a current ratio of 1.44. On the other hand, the Quick Ratio is 1.31, and the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 1.97, the price to book ratio is 2.89 and price to earnings (TTM) ratio is 22.63.
Transactions by insiders
Recent insider trading involved DELANEY MARK E, SVP & Chief Commercial Officer, that happened on May 12 ’25 when 874.0 shares were sold. SVP & Chief Commercial Officer, DELANEY MARK E completed a deal on May 13 ’25 to sell 874.0 shares. Meanwhile, Officer DELANEY MARK E bought 874.0 shares on May 13 ’25.
